CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL
Clinical trial NCT05270772 · UNKNOWN
Trial details
- NCT number
- NCT05270772
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2022-07-15
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.